Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 7, Number 1—February 2001


Active Bacterial Core Surveillance of the Emerging Infections Program Network

Anne Schuchat*Comments to Author , Tami Hilger*, Elizabeth Zell*, Monica M. Farley†, Arthur L. Reingold‡, Lee H. Harrison§, Lewis Lefkowitz¶, Richard Danila**, Karen Stefonek††, Nancy Barrett‡‡, Dale Morse§§, Robert W. Pinner*, and for the Active Bacterial Core Surveillance Team of the Emerging Infections Program Network
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Georgia Emerging Infection Program (Georgia Department of Human Resources, Division of Public Health, Emory University School of Medicine, and the Atlanta Veterans Administration Medical Center) Atlanta, Georgia, USA; ‡California Department of Health Services and UC Berkeley School of Public Health, Berkeley, California, USA; §Maryland Department of Health and Mental Hygiene and Johns Hopkins University School of Public Health, Baltimore, Maryland, USA; ¶Tennessee Department of Health and Vanderbilt University Medical Center, Nashville, Tennessee, USA; **Minnesota Department of Health, St. Paul, Minnesota, USA; ††Oregon Department of Human Resources, Portland, Oregon, USA; ‡‡Connecticut Department of Public Health, Hartford, Connecticut, USA; §§New York State Department of Health, Albany, New York, USA

Main Article

Table 1

Laboratory characterization of isolates collected as part of the Active Bacterial Core surveillance program

Pathogen Test(s)
Group A Streptococcus emm- and T-typing for all invasive isolates; antimicrobial susceptibility testing of periodic samples
Group B Streptococcus Serotyping and antimicrobial susceptibility testing of isolates for selected surveillance areas
Haemophilus influenzae Serotyping of all isolates (a-f); molecular subtyping of isolates as part of special projects
Neisseria meningitidis Molecular subtyping of isolates in conjunction with vaccine development; antimicrobial resistance on isolates periodically
Streptococcus pneumoniae Antimicrobial susceptibility testing for all invasive isolates; serotyping on all invasive isolates since January 1, 1998; subtyping of a sample of isolates using genotyping methods

Main Article